Suppression of Diabetic Retinopathy with Angiopoietin-1
- 1 May 2002
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 160 (5), 1683-1693
- https://doi.org/10.1016/s0002-9440(10)61115-7
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Retinal Vascular Endothelial Growth Factor Induces Intercellular Adhesion Molecule-1 and Endothelial Nitric Oxide Synthase Expression and Initiates Early Diabetic Retinal Leukocyte Adhesion in VivoThe American Journal of Pathology, 2002
- Induction of VEGF Gene Transcription by IL-1 β is Mediated Through Stress-activated MAP Kinases and Sp1 Sites in Cardiac MyocytesJournal of Molecular and Cellular Cardiology, 2000
- Vascular Endothelial Growth Factor Up-regulates ICAM-1 Expression via the Phosphatidylinositol 3 OH-kinase/AKT/Nitric Oxide Pathway and Modulates Migration of Brain Microvascular Endothelial CellsJournal of Biological Chemistry, 2000
- Vascular Endothelial Growth Factor (VEGF)-Induced Retinal Vascular Permeability Is Mediated by Intercellular Adhesion Molecule-1 (ICAM-1)The American Journal of Pathology, 2000
- Angiopoietin-1 Inhibits Endothelial Cell Apoptosis via the Akt/Survivin PathwayJournal of Biological Chemistry, 2000
- Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1Science, 1999
- Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGFScience, 1999
- VEGF Prevents Apoptosis of Human Microvascular Endothelial Cells via Opposing Effects on MAPK/ERK and SAPK/JNK SignalingExperimental Cell Research, 1999
- Endothelial Gaps as Sites for Plasma Leakage in InflammationMicrocirculation, 1999
- Use of Ranks in One-Criterion Variance AnalysisJournal of the American Statistical Association, 1952